Rights, sharing, and embargo policies

“Cell Press supports responsible sharing. We recognize that authors want to share their papers and we encourage this. Find out how you can share your paper here: www.elsevier.com/sharing-articles .

(opens in a new window)

There are, however, some differences between Elsevier’s general policies and those of Cell Press. Most Cell Press articles are under a press embargo until the article is published because we generate substantial media coverage for relevant articles….

We are happy to consider manuscripts previously posted on preprint servers such as arXiv(opens in a new window), bioRxiv(opens in a new window), BioRN(opens in a new window), ChiRxiv(opens in a new window), ChiRN(opens in a new window), or SSRN(opens in a new window). Some of our journals, including Cell Genomics, Cell Reports, Current Biology, and iScience, also support direct submission of manuscripts from bioRxiv and/or medRxiv via transfer of manuscript files and metadata to the journal’s Editorial Manager site. Our support for posting of preprints only applies to the original submitted version of the manuscript; we do not support posting to preprint servers revisions that respond to editorial input and peer review or final accepted manuscripts….

For authors submitting from January 2021 onwards all Cell Press journals offer an open access publishing option. We have a range of journals that are either full open access, where all articles are published on an open access basis, or hybrid open access, which offer a choice between subscription and open access publishing.

Authors of papers published by Cell Press can share their accepted manuscript (the post-peer-review version that does not incorporate copy editing and proofing) via non-commercial hosting platforms, such as their institutional repository, after a posting embargo period has elapsed (this is distinct from the press embargo mentioned above)….

Cell Press open access and hybrid research journals support open access publication for groups of authors from Research4Life (R4L) countries. For papers where all of the authors are from a Group A and/or Group B R4L country we will grant a waiver or discount of the standard publishing fee, as appropriate. For fully open access journals the R4L eligibility check will be automatic. For hybrid journals please highlight your situation to the journal team during the submission process so we can adjust accordingly….”